Literature DB >> 35191936

HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US.

Eshan U Patel1, Becky L Genberg1, Xianming Zhu2, Noa Krawczyk3, Shruti H Mehta1, Aaron A R Tobian2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35191936      PMCID： PMC8864507          DOI： 10.1001/jama.2022.0293

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  5 in total

1.  Opioid Injection in Rural Areas of the United States: A Potential Obstacle to Ending the HIV Epidemic.

Authors:  Andrea M Lerner; Anthony S Fauci
Journal:  JAMA       Date:  2019-09-17       Impact factor: 56.272

2.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

3.  Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs.

Authors:  Marcus A Bachhuber; Chinazo O Cunningham
Journal:  JAMA       Date:  2013-12-25       Impact factor: 56.272

4.  Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic.

Authors:  T Jake Liang; John W Ward
Journal:  N Engl J Med       Date:  2018-03-29       Impact factor: 91.245

Review 5.  A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes.

Authors:  Katelyn F McNamara; Breanne E Biondi; Raúl U Hernández-Ramírez; Noor Taweh; Alyssa A Grimshaw; Sandra A Springer
Journal:  Open Forum Infect Dis       Date:  2021-06-02       Impact factor: 3.835
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.